Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Saudi Arabia
  4. Saudi Arabian Stock Exchange
  5. Dallah Healthcare Company
  6. Summary
    4004   SA135G51UI10

DALLAH HEALTHCARE COMPANY

(4004)
  Report
End-of-day quote Saudi Arabian Stock Exchange  -  2022-11-26
155.00 SAR   -0.26%
11/15Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee
CI
11/10Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
11/01Dallah Healthcare Company Approves Board Appointments
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Saudi Arabian Stock Excha…
11/20/2022 11/21/2022 11/22/2022 11/24/2022 11/27/2022 Date
163 158 155 155.4 155 Last
85062 248670 121759 150716 128132 Volume
-2.28% -3.07% -1.90% +0.26% -0.26% Change
Estimated financial data (e)
Sales 2022 2 438 M 649 M 649 M
Net income 2022 324 M 86,2 M 86,2 M
Net Debt 2022 1 579 M 420 M 420 M
P/E ratio 2022 43,8x
Yield 2022 1,01%
Sales 2023 2 772 M 738 M 738 M
Net income 2023 408 M 109 M 109 M
Net Debt 2023 1 351 M 360 M 360 M
P/E ratio 2023 35,6x
Yield 2023 1,41%
Capitalization 13 950 M 3 713 M 3 713 M
EV / Sales 2022 6,37x
EV / Sales 2023 5,52x
Nbr of Employees -
Free-Float 37,1%
More Financials
Company
Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The HospitalsÔÇÖ segment objectives are to own, manage, operate and maintain healthcare facilities. The MedicinesÔÇÖ segment objectives are to import,... 
More about the company
Ratings of Dallah Healthcare Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about DALLAH HEALTHCARE COMPANY
11/15Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Boar..
CI
11/10Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Month..
CI
11/01Dallah Healthcare Company Approves Board Appointments
CI
09/21Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 20..
CI
08/18Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Month..
CI
05/19Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31..
CI
04/24Dallah Healthcare Company Receives Ministry of Health's Approval to Increase the Operat..
CI
03/24Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31,..
CI
01/25Dallah Healthcare Company signed of a non-binding memorandum of understanding to acquir..
CI
2021اعلان شركة دله ..
PU
2021اعلان شركة دله ..
PU
2021اعلان شركة دله ..
PU
2021اعلان شركة دله ..
PU
2021Dallah Healthcare Co. announces its Interim Financial Results for the Period Ending on ..
PU
2021اعلان شركة دله ..
PU
More news
News in other languages on DALLAH HEALTHCARE COMPANY
11/15Dallah Healthcare Company approuve la démission de Fahad Bin Abdulaziz Al-Rabiah du con..
11/10Dallah Healthcare Company annonce ses résultats pour le troisième trimestre et les neuf..
11/01La société Dallah Healthcare approuve les nominations au conseil d'administration
09/21Dallah Healthcare Co. annonce la distribution de dividendes en espèces pour le premier ..
08/18Dallah Healthcare Company annonce ses résultats pour le deuxième trimestre et le semest..
More news
ETFs positioned on DALLAH HEALTHCARE COMPANYETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares MSCI Saudi Arabia ETF - USD0.72%-2.02%Saudi Arabia
Franklin FTSE Saudi Arabia ETF - USD0.54%-2.14%Saudi Arabia
Invesco Strategic Emerging Markets ETF - USD0.01%0.94%World
IShares Core MSCI All Country World ex Cana...0%-0.80%-World
IShares Core MSCI All Country World ex Cana...0%2.01%World
More ETFs positioned on DALLAH HEALTHCARE COMPANY
Chart DALLAH HEALTHCARE COMPANY
Duration : Period :
Dallah Healthcare Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DALLAH HEALTHCARE COMPANY
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 8
Last Close Price 155,00 SAR
Average target price 120,15 SAR
Spread / Average Target -22,5%
EPS Revisions
Managers and Directors
Ahmad bin Saleh Babaeer Chief Executive Officer
Ali Saeed Jubran Al-Qahtani Chief Financial Officer
Tarek Othman Al-Kasabi Chairman
Abdulaziz Saleh Al-Wahaibi General Director-Administration & Operations
Abdullah bin Turki bin Saad Al-Sudairy Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DALLAH HEALTHCARE COMPANY106.39%3 722
AIER EYE HOSPITAL GROUP CO., LTD.-18.82%26 442
FRESENIUS SE & CO. KGAA-27.40%15 052
BANGKOK DUSIT MEDICAL SERVICES26.09%12 871
IHH HEALTHCARE-18.26%11 789
RAMSAY HEALTH CARE LIMITED-8.90%10 009